SARS-CoV-2 is a potential cause of Guillain-Barré syndrome
Multiple clinical reports and studies support the conclusion that SARS-CoV-2 infection can trigger Guillain-Barré syndrome as an immune-mediated neurological complication.
The retrieved papers consistently document cases and discuss the clinical recognition of Guillain-Barré syndrome following SARS-CoV-2 infection, supporting the claim that the virus is a potential cause of the syndrome.
Josef Finsterer, Fulvio A Scorza. Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires the exclusion of all differential diseases. 2023. https://doi.org/10.47310/iarjcr.2023.v03i01.004
States that Guillain-Barre syndrome is well appreciated as a peripheral nervous system complication of COVID-19.
See more details
Josef Finsterer. Is the Outcome of Sars-Cov-2 Associated Guillain-Barre Syndrome at Variance Between Rich and Poor?. 2022. https://doi.org/10.47310/iarjcr.2022.v01i01.008
Discusses the clinical presentation and management of patients who developed Guillain-Barre syndrome following SARS-CoV-2 infection.
Josef Finsterer, Fulvio A. Scorza. Guillain-Barre Syndrome due to SARS-CoV-2. 2021. https://doi.org/10.47310/iarjms.2021.v02i01.012
Examines cases of Guillain-Barre syndrome directly attributed to SARS-CoV-2 infection.
Fulvio A Scorza, Josef Finsterer. SARS-CoV-2 associated Guillain-Barre syndrome is immune-mediated rather than infectious. 2021. https://doi.org/10.47310/iarjimph.2021.v02i02.020
Notes that SARS-CoV-2 associated Guillain-Barre syndrome occurs, characterizing it as predominantly immune-mediated rather than a direct infectious polyradiculitis.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt